GlassScriptPhysician profile
Morgan G Leak
NPI 1700048006
$772.19
in general payments reported to CMS, 2019-2025
14 companies · $43.41 in 2025
The $43.41 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $28.93 · 2021: $90.35 · 2022: $96.26 · 2023: $162 · 2024: $126 · 2025: $43.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $325.28 | 2019-2023 | Trelegy Ellipta, Bexsero, Rotarix |
| Astrazeneca Pharmaceuticals LP | $206.55 | 2019-2024 | Farxiga, Airsupra |
| Insulet Corporation | $47.90 | 2024-2025 | Omnipod |
| Novo Nordisk INC | $29.16 | 2019 | |
| Janssen Pharmaceuticals, INC | $27.38 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $22.78 | 2024 | |
| Sanofi Pasteur INC. | $19.64 | 2019 | |
| Merck Sharp & Dohme LLC | $16.49 | 2020 | |
| Dexcom, INC. | $15.28 | 2021 | |
| Phathom Pharmaceuticals, INC. | $14.93 | 2024 | Voquezna |
| Medtronic, INC. | $14.07 | 2025 | Minimed 780g |
| Medtronic Minimed, INC. | $12.44 | 2020 | |
| Pfizer INC. | $11.91 | 2019 | |
| Organon LLC | $8.38 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Leak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.